Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Lesalpes29on Jan 12, 2023 6:18am
172 Views
Post# 35217614

RE:Little or no institutional and insider ownership

RE:Little or no institutional and insider ownership
oilfiftybucks wrote:

90%+ owned by retail investors aka bagholders (I am now one)
volume dryed up, only sellers showing up to the party. 

I think i was sold a false bill of goods. Seriously wonder why no institutional buying if there is a deal looming in the next year. I took the time to study some of the other successful cancer research companies that were bought out amd oncy is not showing any similar patterns. Time to move on i guess. Good luck longs. 


An other one... an other creation made to suggest us to sell when he just bought 100k shares! You can already move on you, ower new friend! Have good results and a good futur and they will come! Stay in the game longs if you can. Show time!
<< Previous
Bullboard Posts
Next >>